EMEA-000265-PIP02-11-M03
Key facts
| Invented name |
Simponi
|
| Active substance |
Golimumab
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0157/2021
|
| PIP number |
EMEA-000265-PIP02-11-M03
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of ulcerative colitis
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Janssen Biologics B.V.
Tel. +32 1460 2111 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|